natgillin/translations-raw huggingface dataset:
Serious immune based adverse reactions that are associated with medicinal products containing a sulfonamide group include rash, allergic reaction and major haematological disturbances, including aplastic anaemia, which very rarely can be fatal. 
Z zdravili, ki vsebujejo sulfonamidno skupino, so povezani resni neželeni učinki imunskega izvora, ki vključujejo izpuščaj, alergijske reakcije in večje hematološke motnje, vključno z aplastično anemijo, ki so zelo redko lahko s smrtnim izidom.
Fatigue Pyrexia Irritability 
Splošne težave in spremembe na mestu aplikacije utrujenost pireksija razdražljivost
PVC-PVdC/Aluminium foil blisters in cardboard cartons containing 14, 28 and 56 capsules. 
PVC/PVdC/aluminijevi pretisni omoti v škatli s po 14, 28 in 56 trdimi kapsulami.
Increase at twoweekly intervals in increments of 1 mg/kg 
Povečanje v dvotedenskih intervalih po največ 1 mg/kg
Zonisamide Mylan can cause your child to sweat less and overheat and if your child is not treated this can lead to brain damage and death. 
Zdravilo Zonisamid Mylan lahko povzroči, da se vaš otrok manj znoji in se pregreje.
Hyperchloraemic, non-anion gap, metabolic acidosis (i.e. decreased serum bicarbonate below the normal reference range in the absence of chronic respiratory alkalosis) is associated with zonisamide treatment. 
znižan serumski bikarbonat pod normalno referenčno vrednost in v odsotnosti kronične respiratorne alkaloze).
PVC-PVdC/Aluminium foil perforated unit dose blisters in cardboard cartons containing 14 x 1 capsules. 
Perforirani PVC/PVdC/aluminijevi pretisni omoti za posamezni odmerek v škatli s po 14 x 1 trdo kapsulo.
Mylan Healthcare SIA Tel: + 371 676 055 80 
Tel: + 371 676 055 80
Zonisamide should not be used as co-medication in paediatric patients with other carbonic anhydrase inhibitors such as topiramate and acetazolamide (see section 4.4: Paediatric population). 
Zonisamida pri pediatričnih bolnikih ni dovoljeno uporabljati sočasno z drugimi zaviralci karboanhidraze, kot sta topiramat in acetazolamid (glejte poglavje 4.4 Pediatrična populacija).
- The recommended daily dose is between 300 mg and 500 mg. - Some people respond to lower doses. 
• Priporočeni dnevni odmerek je med 300 mg in 500 mg.
blurred vision or decreased vision may occur and can be signs of glaucoma. 
Lahko se pojavijo bolečine v očeh, zamegljen vid ali zmanjšana ostrina vida, ki so lahko znaki glavkoma.
Abdominal pain Constipation Diarrhoea Dyspepsia Nausea 
Bolezni prebavil bolečina v trebuhu konstipacija diareja dispepsija navzea bruhanje pankreatitis
Pneumonia aspiration Respiratory disorder Hypersensitivity-type Pneumonitis 
Bolezni dihal, prsnega koša in mediastinalnega prostora dispnea aspiracijska pljučnica motnje dihanja preobčutljivostni pnevmonitis
How to take Zonisamide Mylan 
Kako jemati zdravilo Zonisamid Mylan
Reduce the risk of kidney stones by drinking sufficient water - live in a place or are on holiday in a place where the weather is warm. 
Zmanjšajte nevarnost pregretja telesa z uživanjem zadostne količine vode in zadrževanjem v hladnejšem okolju;
Status epilepticus 
Antiepileptična zdravila
Bradyphrenia Disturbance in attention Nystagmus Paraesthesia Speech disorder Tremor 
Bolezni živčevja ataksija omotica okrnjene spominske sposobnosti zaspanost bradifrenija motnje pozornosti parestezija nistagmus motnje govora tremor konvulzije
METHOD AND ROUTE OF ADMINISTRATION 
POSTOPEK IN POT UPORABE ZDRAVILA
PVC-PVdC/Aluminium foil perforated unit dose blisters in cardboard cartons containing 56 x 1 capsules. 
Perforirani PVC/PVdC/aluminijevi pretisni omoti za posamezni odmerek v škatli s po 56 x 1 trdo kapsulo.
A meta-analysis of randomised placebo-controlled trials of anti-epileptic medicinal products has also shown a small increased risk of suicidal ideation and behaviour. 
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih s placebom nadzorovanih kliničnih preskušanj antiepileptikov.
Week 2 Week 3 to 5 
+ 2. teden 3.
Reduce the risk of overheating by drinking sufficient water and keeping cool - are underweight, or have lost a lot of weight as Zonisamide Mylan can cause you to lose more weight. 
• če imate premajhno telesno maso ali če ste zelo shujšali, ker je mogoče, da boste zaradi zdravila Zonisamid Mylan še bolj shujšali.
Zonisamide Mylan belongs to a group of medicines (sulfonamides) which can cause severe allergic reactions, severe skin rashes, and blood disorders, which very rarely can be fatal (see section 4. 
Zdravilo Zonisamid Mylan pripada skupini zdravil (sulfonamidi), ki lahko povzročajo hude alergijske reakcije, hude kožne izpuščaje in bolezni krvi, ki zelo redko lahko povzročijo smrt (glejte poglavje 4, Možni neželeni učinki).
Zonisamide Mylan 100 mg hard capsules have a white body and white cap, marked ‘Z 100' in black and contain a white/almost white powder. 
Zonisamid Mylan 100 mg trde kapsule imajo belo neprozorno telo in bel neprozoren pokrovček, označene so z napisom ‘Z 100' v črni barvi in vsebujejo bel/belkast prašek.
Agranulocytosis Aplastic anaemia Leucocytosis Leucopoenia Lymphadenopathy Pancytopenia, Thrombocytopenia 
Bolezni krvi in limfatičnega sistema ekhimoza agranulocitoza aplastična anemija levkocitoza levkopenija limfadenopatija pancitopenija trombocitopenija
A very high plasma concentration of 100.1 μg/ml zonisamide was recorded approximately 31 hours after a patient took an overdose of zonisamide and clonazepam; the patient became comatose and had respiratory depression, but recovered consciousness five days later and had no sequelae. 
Pri bolniku, ki je zaužil prevelik odmerek zonisamida in klonazepama, se je po približno 31 urah pojavila zelo visoka plazemska koncentracija zonisamida (100,1 μg/ml).
Zonisamide Mylan 25 mg hard capsules Zonisamide Mylan 50 mg hard capsules Zonisamide Mylan 100 mg hard capsules zonisamide 
Zonisamid Mylan 25 mg trde kapsule Zonisamid Mylan 50 mg trde kapsule Zonisamid Mylan 100 mg trde kapsule zonisamid
Zonisamide is metabolised partly by CYP3A4 (reductive cleavage), and also by N-acetyl-transferases and conjugation with glucuronic acid; therefore, substances that can induce or inhibit these enzymes may affect the pharmacokinetics of zonisamide: 
Zonisamid se delno presnavlja s CYP3A4 (reduktivna cepitev) ter N-acetil-transferazo in konjugira z glukuronsko kislino.
Musculoskeletal and connective tissue disorders 
Bolezni mišičnoskeletnega sistema in vezivnega tkiva rabdomioliza
Talk to your doctor or pharmacist before taking Zonisamide Mylan if you: 
Pred začetkom jemanja zdravila Zonisamid Mylan se posvetujte z zdravnikom ali farmacevtom:
Zonisamide can cause children to sweat less and overheat and if the child is not treated this can lead to brain damage and death. 
Če se to stanje pri otroku ne zdravi, lahko povzroči poškodovanje možganov in smrt.
Zonisamide Mylan 25 mg hard capsules have a white body and a white cap, marked ‘Z 25' in black and contain a white/almost white powder. 
Zonisamid Mylan 25 mg trde kapsule imajo belo neprozorno telo in bel neprozoren pokrovček, označene so z napisom ‘Z 25' v črni barvi in vsebujejo bel/belkast prašek.
Renal ultrasound should be performed at the discretion of the physician. 
Po presoji zdravnika se opravi ultrazvok ledvic.
Skin and subcutaneous tissue disorders 
Bolezni kože in podkožja izpuščaj pruritus ekhimoza
Zonisamide Mylan 50 mg hard capsules have a white body and white cap, marked ‘Z 50' in red and contain a white/almost white powder. 
Zonisamid Mylan 50 mg trde kapsule imajo belo neprozorno telo in bel neprozoren pokrovček, označene so z napisom ‘Z 50' v rdeči barvi in vsebujejo bel/belkast prašek.
A dietary supplement or increased food intake should be considered if the patient is failing to gain weight in accordance with growth charts, otherwise zonisamide should be discontinued. 
Če bolnik ne pridobiva telesne mase v skladu z rastnimi krivuljami, je treba razmisliti o uporabi prehranskih dopolnil ali pa zdravljenje z zonisamidom prekiniti.
Zonisamide Mylan 25 mg and 50 mg hard capsules 
Zonisamid Mylan 25 mg in 50 mg trde kapsule
How to store Zonisamide Mylan 
Shranjevanje zdravila Zonisamid Mylan
Zonisamide Mylan 25 mg hard capsules Zonisamide Mylan 50 mg hard capsules Zonisamide Mylan 100 mg hard capsules 
Zonisamid Mylan 25 mg trde kapsule Zonisamid Mylan 50 mg trde kapsule Zonisamid Mylan 100 mg trde kapsule
Respiratory, thoracic and mediastinal disorders 
Bolezni dihal, prsnega koša in mediastinalnega prostora dihalne motnje
Do not reduce your dose or stop your medicine unless your doctor tells you to. - If your doctor advises you to stop taking Zonisamide Mylan your dose will be reduced gradually to lower the risk of more seizures. 
• Če vam bo zdravnik svetoval, da prenehajte jemati zdravilo Zonisamid Mylan, vam bo odmerek zmanjševal postopoma, da bi zmanjšal nevarnost pogostnejših epileptičnih napadov.
Agitation Irritability Confusional state 
• agitacija, razdražljivost, zmedenost, depresivnost;
200 mg/day (once a day) 
200 mg/dan (enkrat na dan)
Respiratory disorder 
• motnje dihanja;
Uncommon Very Rare 
Zelo redki
The risk of birth defect is increased by factor 2 to 3 in the offspring of mothers treated with an antiepileptic medicinal product. 
Pri otrocih mater, zdravljenih z antiepileptiki, se tveganje za prirojene okvare zveča za dva do trikrat.
The main route of excretion of zonisamide metabolites and unchanged drug is via the urine. 
Zonisamid in njegovi presnovki se pretežno izločajo z urinom.
Each hard capsule contains 100 mg zonisamide. 
Ena trda kapsula vsebuje 100 mg zonisamida.
Constipation Diarrhoea Dyspepsia Nausea Vomiting 
Bolezni prebavil zaprtje driska dispepsija navzea bruhanje bolečina v trebuhu
Ataxia 
Dojenje
Urinary tract infection Pneumonia 
Infekcijske in parazitske bolezni pljučnica okužba sečil
Iron oxide Red (E172) 
Tiskarsko črnilo šelak rdeči železov oksid (E172) 6.2 Inkompatibilnosti
Examples include: sulfonamide antibiotics, thiazide diuretics, and sulfonylurea antidiabetes medicines. 
tiazidni diuretiki in sulfonilsečnine (zdravila za sladkorno bolezen).
300 mg/day (once a day) 
300 mg/dan (enkrat na dan)
100 mg/day (once a day) 
100 mg/dan (enkrat na dan)
Caution is advised when starting or stopping zonisamide treatment or changing the zonisamide dose in patients who are also receiving medicinal products which are P-gp substrates (e.g. digoxin, quinidine). 
Pri bolnikih, ki prejemajo tudi zdravila, ki so substrati P-gp (npr. digoksin, kinidin), je pri uvajanju ali ukinjanju zdravljenja z zonisamidom ali spreminjanju odmerka zonisamida potrebna previdnost.
Zonisamide Mylan 100 mg hard capsules zonisamide 
Zonisamid Mylan 100 mg trde kapsule zonisamid
If you stop taking Zonisamide Mylan - Zonisamide Mylan is meant to be taken as a long-term medicine. 
• Zdravilo Zonisamid Mylan je zdravilo, ki je namenjeno za dolgotrajno zdravljenje.
PHARMACOLOGICAL PROPERTIES 
Farmakodinamični učinki
Zonisamide Mylan 25 mg hard capsules zonisamide 
Zonisamid Mylan 25 mg trde kapsule zonisamid
Each capsule contains 25 mg of zonisamide. 
Ena kapsula vsebuje 25 mg zonisamida.
Each hard capsule contains 25 mg zonisamide. 
Ena trda kapsula vsebuje 25 mg zonisamida.
Withdrawal seizures 
PRETISNI OMOT
Each capsule contains 50 mg of zonisamide. 
Ena kapsula vsebuje 50 mg zonisamida.
Specialist advice should be given to women treated with zonisamide who are of childbearing potential. 
Ženskam v rodni dobi, zdravljenih z zonisamidom, mora svetovati zdravnik specialist.
Fatigue Influenza-like illness 
Splošne težave in spremembe na mestu aplikacije utrujenost gripi podobna bolezen pireksija periferni edem
PP-population* ITT-population < 4 seizures during 3 month baseline period > 4 seizures during 3 month baseline period 
≤ 4 epileptični napadi med 3mesečnim izhodiščnim obdobjem
Zonisamide Mylan 100 mg hard capsules 
Zonisamid Mylan 100 mg trde kapsule
A small number of people being treated with anti epileptics such as Zonisamide Mylan have had thoughts of harming or killing themselves- have pain in your muscles or a feeling of weakness, as this may be a sign of abnormal muscle breakdown which can lead to kidney problems - get a sudden pain in your back or stomach, have pain on urinating (passing water) or notice blood in your urine, as this may be a sign of kidney stones - develop visual problems such as eye pain or blurred vision while taken zonisamide. 
• če se pojavijo nenadne bolečine v hrbtu ali trebuhu, imate bolečine pri uriniranju (odvajanju vode) ali opazite kri v urinu, ker so to lahko znaki ledvičnih kamnov.
The other ingredients are: - capsule contents: microcrystalline cellulose, hydrogenated vegetable oil and sodium laurilsulfate - capsule shell: gelatin and titanium dioxide (E171) - printing ink: shellac, black iron oxide (E172) and potassium hydroxide. 
- Tiskarsko črnilo: šelak, črni železov oksid (E172) in kalijev hidroksid.
Each hard capsule contains 50 mg zonisamide. 
Ena trda kapsula vsebuje 50 mg zonisamida.
Zonisamide Mylan 50 mg hard capsules zonisamide 
Zonisamid Mylan 50 mg trde kapsule zonisamid
A dietary supplement or increased food intake may be considered if the patient is losing weight or is underweight whilst on this medication. 
V primeru, da bolnik med zdravljenjem z zonisamidom izgublja telesno maso ali pa ima prenizko telesno maso, je treba razmisliti o prehranskih dopolnilih ali povečanem vnosu hrane.
Contact your doctor immediately if you: - have difficulty breathing, a swollen face, lips or tongue, or a severe skin rash as these symptoms may indicate that you are having a severe allergic reaction - have signs of overheating - high body temperature but little or no sweating, rapid heartbeat and breathing, muscle cramps, and confusion - have thoughts of harming or killing yourself. 
• če se pojavijo znaki pregretja - visoka telesna temperatura z malo ali brez potenja, hiter srčni utrip in dihanje, mišični krči in zmedenost;
The other ingredients are: - capsule contents: microcrystalline cellulose, hydrogenated vegetable oil and sodium laurilsulfate - capsule shell: gelatin and titanium dioxide (E171) - printing ink: shellac and iron oxide red (E172) 
Druge sestavine zdravila so: - Vsebina kapsule: mikrokristalna celuloza, hidrogenirano rastlinsko olje in natrijev lavrilsulfat.
Zonisamide Mylan 50 mg hard capsules 
Zonisamid Mylan 50 mg trde kapsule
Zonisamide Mylan 25 mg hard capsules 
Zonisamid Mylan 25 mg trde kapsule
Blood urea increased Liver function tests abnormal 
• nenormalni izvidi testov funkcije jeter.
When you take Zonisamide Mylan with other antiepileptic medicines: - The starting dose is 50 mg daily taken in two equal doses of 25 mg. - This may be increased by up to 100 mg at intervals of one to two weeks. 
• Začetni odmerek je 50 mg na dan, razdeljen v dva enaka odmerka po 25 mg.
Zonisamide Mylan 100 mg hard capsules. 
Zonisamid Mylan 100 mg trde kapsule:
Agitation Depression Insomnia Mood swings Anxiety 
Psihiatrične motnje vznemirjenost razdražljivost zmedenost depresija čustvena labilnost anksioznost nespečnost psihotične motnje jeza agresija samomorilna nagnjenja poskus samomora halucinacije
Each hard capsule is approximately 14.4 mm in length. 
Vsaka trda kapsula je dolga približno 14,4 mm. Zonisamid Mylan 50 mg trde kapsule
Cognition 
Kognitivne funkcije
Be especially careful while driving or operating machinery if Zonisamide Mylan affects you in this way. 
Če zdravilo Zonisamid Mylan vpliva na vas na ta način, bodite med vožnjo in upravljanjem s stroji še posebno previdni.
Zonisamide is 40 - 50 % bound to human plasma proteins, with in vitro studies showing that this is unaffected by the presence of various antiepileptic medicinal products (i.e., phenytoin, phenobarbitone, carbamazepine, and sodium valproate). 
In vitro študije so pokazale, da prisotnost drugih antiepileptičnih zdravil (kot npr. fenitoin, fenobarbiton, karbamazepin in natrijev valproat) ne vpliva na vezavo na proteine.
Grand mal seizure Myasthenic syndrome Neuroleptic malignant syndrome 
Bolezni živčevja ataksija omotica poslabšanje spomina somnolenca bradifrenija motnje pozornosti nistagmus parestezije motnje govora tremor konvulzije amnezija koma epileptični napad grand mal miastenijski sindrom nevroleptični maligni sindrom epileptični status
Zonisamide Mylan 25 mg and 100 mg hard capsules 
6.1 Seznam pomožnih snovi Zonisamid Mylan 25 mg in 100 mg trde kapsule
Contact your doctor as soon as possible if you: - have an unexplained skin rash, as this could develop into a more severe skin rash or skin peeling - feel unusually tired or feverish, have a sore throat, swollen glands, or find that you bruise more easily, as this may mean you have a blood disorder - have signs of increased acid level in the blood- headaches, drowsiness, shortness of breath and loss of appetite. 
• če se počutite nenavadno utrujeni ali vročični, imate vneto žrelo, otekle bezgavke ali opazite, da vam brez omembe vrednega vzroka nastajajo modrice, ker bi to lahko pomenilo, da imate bolezen krvi;
Week 1 + 2 Week 3 + 4 Week 5 + 6 
+ 4. teden 5.
Zonisamide Mylan 50 mg hard capsules. 
Zonisamid Mylan 50 mg trde kapsule:
You must only take Zonisamide Mylan during your pregnancy if your doctor tells you to. Research has shown an increased risk of birth defects in children of women taking anti-epileptic medicines. 
Med nosečnostjo lahko jemljete zdravilo Zonisamid Mylan le v primeru, da vam je tako svetoval zdravnik.
500 mg/day (once a day) 
300 - 500 mg/dan (enkrat na dan)
- shortness of breath, inflammation of the lungs - inflammations of the pancreas (severe pain in the stomach or back) - liver problems, kidney failure - severe rashes or skin peeling (at the same time you may feel unwell or develop a fever) - abnormal muscle breakdown (you may feel pain or weakness in your muscles) which can lead to kidney problems - swollen glands, blood disorders (reduction in the number of blood cells, which can make infection more likely and can make you look pale, feel tired and feverish, and bruise more easily) - decreased sweating, overheating - problems with your urine - increased blood levels of creatine phosphokinase or urea which can be seen in a blood test - abnormal results from liver function tests - glaucoma, which is a blockage of fluid in the eye causing increased pressure in the eye. 
• otekle bezgavke, bolezni krvi (zmanjšanje števila krvničk, zaradi katerega ste dovzetnejši za okužbe, ste bledi, utrujeni in vročični ter bolj nagnjeni k nastanku modric);
Consideration must be given to discontinuing zonisamide in patients who develop an otherwise unexplained rash. 
Pri bolnikih, pri katerih se razvije izpuščaj, ki ga ni mogoče razložiti na noben drug način, je treba pretehtati možnost ukinitve zonisamida.
The full EPAR for Ingelvac CircoFLEX can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports. 
Celotno evropsko javno poročilo o oceni zdravila Ingelvac CircoFLEX je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Ingelvac CircoFLEX's benefits are greater than its risks and recommended that it be approved for use in the EU. 
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Ingelvac CircoFLEX večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The most common side effect with Ingelvac CircoFLEX (which may affect more than 1 in 10 animals) is a mild and short lived increase in body temperature on the day of vaccination. 
Najpogostejši neželeni učinek zdravila Ingelvac CircoFLEX (ki lahko prizadene več kot 1 od 10 živali) je blago in kratkotrajno povišanje telesne temperature na dan cepljenja.
This is a summary of the European public assessment report (EPAR) for Ingelvac CircoFLEX. 
To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Ingelvac CircoFLEX.
The European Commission granted a marketing authorisation valid throughout the EU for Ingelvac CircoFLEX on 13 February 2008. 
Evropska komisija je dovoljenje za promet z zdravilom Ingelvac CircoFLEX, veljavno po vsej Evropski uniji, izdala 13. februarja 2008.
response will help to protect the pig against the disease caused by this virus. 
Aktivni imunski odziv prispeva k zaščiti prašiča pred boleznijo, ki jo ta virus povzroča.
It also reduced the levels of PCV2 in the blood, clinical signs of PCV2 infection, the number of runts and death rates. 
Zmanjšale so se tudi ravni PCV2 v krvi, klinični znaki okužbe s PCV2, število živali, ki zaostajajo v rasti, in umrljivost.
In the future, the immune system will be able to react against the virus more quickly when it is exposed to the virus. 
ponovni izpostavitvi virusu v prihodnosti imunski sistem lahko hitreje reagiral proti njemu.
Other information about Ingelvac CircoFLEX: 
Druge informacije o zdravilu Ingelvac CircoFLEX:
It is not intended to provide practical advice on how to use Ingelvac CircoFLEX. 
Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
The withdrawal period for meat from pigs treated with Ingelvac CircoFLEX is ‘zero days', which means there is no mandatory waiting time. 
Karenca za meso prašičev, zdravljenih s cepivom Ingelvac CircoFLEX, je nič dni, kar pomeni, da ni obvezne čakalne dobe.
The trials showed that vaccination of pigs with Ingelvac CircoFLEX reduced weight loss in the piglets. 
Preskušanja so pokazala, da cepljenje prašičev z zdravilom Ingelvac CircoFLEX zmanjša izgubo telesne mase pri pujskih.
Ingelvac CircoFLEX is a vaccine. 
Zdravilo Ingelvac CircoFLEX je cepivo.
Ingelvac CircoFLEX has been studied in a number of trials involving pigs of various breeds. 
Zdravilo Ingelvac CircoFLEX je bilo preučeno v več preskušanjih, ki so vključevala prašiče različnih pasem.
For the full list of restrictions and all side effects reported with Ingelvac CircoFLEX, see the package leaflet. 
Za celoten seznam omejitev in neželenih učinkov, o katerih so poročali pri uporabi zdravila Ingelvac CircoFLEX, glejte navodilo za uporabo.
Ingelvac CircoFLEX is available as a suspension for injection and can only be obtained with a prescription. 
Zdravilo Ingelvac CircoFLEX je na voljo v obliki suspenzije za injiciranje, njegovo predpisovanje in izdaja pa je le na recept.
porcine circovirus type 2 vaccine 
cepivo proti prašičjemu cirkovirusu tipa 2
Ingelvac CircoFLEX is a vaccine used to protect pigs from the two weeks of age against porcine circovirus type 2 (PCV2). 
Ingelvac CircoFLEX je cepivo za zaščito prašičev od starosti dveh tednov dalje proti prašičjemu cirkovirusu tipa 2 (PCV2).
For more information about treatment with Ingelvac CircoFLEX, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist. 
Za več informacij o zdravljenju z zdravilom Ingelvac CircoFLEX naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
Ingelvac CircoFLEX contains small amounts of a protein from PCV2. 
Zdravilo Ingelvac CircoFLEX vsebuje majhne količine beljakovine iz virusa PCV2.
What is Ingelvac CircoFLEX and what is it used for? 
Kaj je zdravilo Ingelvac CircoFLEX in za kaj se uporablja?
For practical information about using Ingelvac CircoFLEX, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist. 
Za praktične informacije o uporabi zdravila Ingelvac CircoFLEX naj lastniki ali skrbniki živali preberejo navodilo za uporabo ali se posvetujejo z veterinarjem ali farmacevtom.
Why is Ingelvac CircoFLEX approved? 
Zakaj je bilo zdravilo Ingelvac CircoFLEX odobreno?
What are the risks associated with Ingelvac CircoFLEX? 
Kakšna tveganja so povezana z zdravilom Ingelvac CircoFLEX?
What benefits of Ingelvac CircoFLEX have been shown in studies? 
Kakšne koristi je zdravilo Ingelvac CircoFLEX izkazalo v študijah?
Ingelvac CircoFLEX contains the active substance porcine circovirus type 2 ORF2 protein. 
Zdravilo Ingelvac CircoFLEX vsebuje zdravilno učinkovino beljakovino ORF2 prašičjega cirkovirusa tipa 2.
How is Ingelvac CircoFLEX used? 
Kako se zdravilo Ingelvac CircoFLEX uporablja?